‘Ironwood Pharma: dedicated to making a difference for people living with GI diseases’
Ironwood Pharmaceuticals is a leading biopharmaceutical company dedicated to patient-centric innovation in gastrointestinal (GI) healthcare and on a mission to push the boundaries of the GI field by advancing the treatment of GI diseases and redefining the standard of care for GI patients.
We named ourselves after the Ironwood tree, which can live for thousands of years in the harshest desert, creating a shaded microclimate in which life thrives. This symbolism aligns with our passion for impacting the health and lives of GI patients, their families, and communities and cultivating an inclusive, supportive environment for our employees.
Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts, and has an additional site in Basel, Switzerland.
Visit us at: www.ironwoodpharma.com
Visit ClinicalTrials.gov to learn more about our proof-of-concept study in steroid-refractory gastrointestinal acute Graft-versus-Host-Disease